NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-257-2010-0-RS-78 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RS EP 18165005.2 Issued
NCATS E-257-2010-0-NL-62 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NL EP 18165005.2 Issued
NCATS E-257-2010-0-MT-77 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators MT EP 18165005.2 Issued
NCATS E-257-2010-0-LU-75 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LU EP 18165005.2 Issued
NCATS E-257-2010-0-LV-76 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LV EP 18165005.2 Issued
NCATS E-257-2010-0-LT-74 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LT EP 18165005.2 Issued
NCATS E-257-2010-0-LI-61 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LI EP 18165005.2 Issued
NCATS E-257-2010-0-EP-18 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EP DIV 18165005.2 Issued
NCATS E-257-2010-0-GB-56 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GB EP 18165005.2 Issued
NCATS E-257-2010-0-TR-69 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators TR EP 18165005.2 Issued
NCATS E-257-2010-0-CH-49 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CH EP 18165005.2 Issued
NIAID E-102-2018-0-PCT-02 Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation PCT PCT PCT/US2018/025044 Expired
NINDS E-024-2016-1-US-03 METHODS OF TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS US National Stage 15/764,647 Abandoned
NCI E-105-2018-0-US-01 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data US 62/650,162 Abandoned
NCATS E-252-2017-0-US-01 METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE US 62/650,147 Abandoned
NCI E-208-2015-0-US-07 THALIDOMIDE ANALOGS AND METHODS OF USE US National Stage 15/764,193 10730835 Issued PDF
NIAID E-099-2016-0-US-03 Use Of Roseomonas Species To Treat Eczematous Skin Disease US National Stage 15/939,066 10195236 Issued PDF
NCI E-067-2017-0-PCT-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES PCT PCT PCT/US2018/024828 Expired
NCI E-067-2017-0-CA-04 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CA National Stage 3057375 Pending
NIAID E-256-2015-2-GB-12 Modified Anthrax Toxin Protective Antigen GB EP 16767065.2 Issued
NIAID E-256-2015-2-EP-05 Modified Anthrax Toxin Protective Antigen EP National Stage 16767065.2 Issued
NIAID E-256-2015-2-FR-11 Modified Anthrax Toxin Protective Antigen FR EP 16767065.2 Issued
NIAID E-256-2015-2-DE-10 Modified Anthrax Toxin Protective Antigen DE EP 16767065.2 Issued
NCI E-269-2011-0-JP-08 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) JP DIV 2018-057959 Issued
CC E-076-2017-0-PCT-02 METHOD AND SYSTEM OF BUILDING HOSPITAL-SCALE CHEST X-RAY DATABASE FOR ENTITY EXTRACTION AND WEAKLY-SUPERVISED CLASSIFICATION AND LOCALIZATION OF COMMON THORAX DISEASES PCT PCT PCT/US2018/024354 Expired
NIAID E-083-2017-0-PCT-02 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE PCT PCT PCT/US2018/024330 Expired
NIAID E-083-2017-0-EP-04 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE EP National Stage 18721513.2 Pending
NCI E-100-2018-0-US-01 ACTIVATORS OF TYPE II NKT CELLS AND METHODS OF USE THEREOF US 62/648,167 Abandoned
NIAID E-256-2015-2-AU-02 Modified Anthrax Toxin Protective Antigen AU National Stage 2016311429 Issued
NCI E-116-2017-0-CN-07 Human Antibodies Against CD33 CN National Stage 201880032715.1 Issued
NIDDK E-112-2018-0-US-02 Methods For Pharmacologic Treatment Of Ischemic Stroke US ORD 15/933,536 10695355 Issued PDF
NIDDK E-213-2015-0-US-05 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS US National Stage 15/762,852 10683277 Issued PDF
NCATS E-072-2015-0-US-17 Sensor And Device For Real Time Detection Of Metabolites In Blood US DIV 15/933,834 10620187 Issued PDF
NCI E-116-2017-0-US-02 Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy US ORD 15/934,770 10426797 Issued PDF
NCI E-116-2017-0-PCT-04 Human Antibodies Against CD33 PCT PCT PCT/US2018/024183 Expired
NCI E-116-2017-0-CN-10 Human Antibodies Against CD33 CN DIV 202011342007.3 Pending
NCI E-116-2017-0-EP-08 Human Antibodies Against CD33 EP National Stage 18721179.2 Pending
NCI E-116-2017-0-JP-09 Human Antibodies Against CD33 JP National Stage 2019-552109 Pending
NCI E-116-2017-0-CA-06 Human Antibodies Against CD33 CA National Stage 3057838 Pending
NCI E-116-2017-0-AU-05 Human Antibodies Against CD33 AU National Stage 2018240556 Pending
NIDCR E-190-2015-0-EP-03 Methods Of Using Neodymium Magnet For Rapid Diagnosis Of Infectious And Autoimmune Diseases EP National Stage 16751139.3 Abandoned
NIAID E-256-2015-2-KR-08 Modified Anthrax Toxin Protective Antigen KR National Stage 2018-7008131 Issued
NEI E-212-2015-0-AU-03 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS AU National Stage 2016321170 Issued
NCI E-243-2015-0-DE-06 Anti-CD276 Chimeric Antigen Receptors DE EP 16770410.5 Issued
NCI E-243-2015-0-FR-07 Anti-CD276 Chimeric Antigen Receptors FR EP 16770410.5 Issued
NCI E-243-2015-0-GB-08 Anti-CD276 Chimeric Antigen Receptors GB EP 16770410.5 Issued
NCI E-243-2015-0-EP-03 Anti-CD276 Chimeric Antigen Receptors EP National Stage 16770410.5 Issued
NHLBI E-273-2015-0-US-04 Endo-cameral Closure Device US National Stage 15/761,923 10603021 Issued PDF
NIDDK E-034-2015-0-HK-05 Device and System for Manipulating Small Model Organisms HK National Stage 18103848.8 Abandoned
NINR E-222-2018-0-US-01 Instrumentation-Free Paper Oragami Rapid Molecular Diagnostic Device US 62/645,449 Abandoned